New England Journal of Medicine · 2019 · 30 citations · 14 references
MedicineObstetricsSurgeryObstetric SurgeryReproductive MedicineReproductive SurgeryAbortion CareAntibiotic ProphylaxisAntimicrobial ProphylaxisProphylactic Antimicrobial UseSurgical Infection ManagementSurgical ProphylaxisAntibiotic Prophylaxis In SurgeryAntibiotic Therapy In PregnancyIntrapartum Antibiotic ProphylaxisMaternal Antibiotic ProphylaxisMaternal-intrapartum Antibiotic ProphylaxisObstetric Antimicrobial ProphylaxisObstetric ProphylaxisPelvic Infection Prevention
BACKGROUND: Surgical intervention is needed in some cases of spontaneous abortion to remove retained products of conception. Antibiotic prophylaxis may reduce the risk of pelvic infection, which is an important complication of this surgery, particularly in low-resource countries. METHODS: We conducted a double-blind, placebo-controlled, randomized trial investigating whether antibiotic prophylaxis before surgery to complete a spontaneous abortion would reduce pelvic infection among women and adolescents in low-resource countries. We randomly assigned patients to a single preoperative dose of 400 mg of oral doxycycline and 400 mg of oral metronidazole or identical placebos. The primary outcome was pelvic infection within 14 days after surgery. Pelvic infection was defined by the presence of two or more of four clinical features (purulent vaginal discharge, pyrexia, uterine tenderness, and leukocytosis) or by the presence of one of these features and the clinically identified need to administer antibiotics. The definition of pelvic infection was changed before the unblinding of the data; the original strict definition was two or more of the clinical features, without reference to the administration of antibiotics. RESULTS: We enrolled 3412 patients in Malawi, Pakistan, Tanzania, and Uganda. A total of 1705 patients were assigned to receive antibiotics and 1707 to receive placebo. The risk of pelvic infection was 4.1% (68 of 1676 pregnancies) in the antibiotics group and 5.3% (90 of 1684 pregnancies) in the placebo group (risk ratio, 0.77; 95% confidence interval [CI], 0.56 to 1.04; P = 0.09). Pelvic infection according to original strict criteria was diagnosed in 1.5% (26 of 1700 pregnancies) and 2.6% (44 of 1704 pregnancies), respectively (risk ratio, 0.60; 95% CI, 0.37 to 0.96). There were no significant between-group differences in adverse events. CONCLUSIONS: Antibiotic prophylaxis before miscarriage surgery did not result in a significantly lower risk of pelvic infection, as defined by pragmatic broad criteria, than placebo. (Funded by the Medical Research Council and others; AIMS Current Controlled Trials number, ISRCTN97143849.).
14
Teresa Horan, Mary Andrus, Margaret A. Dudeck · American Journal of Infection Control · 2008 · 6.6K citations
Public Health, Infectious Disease Control, Infectious Diseases +16
Incidence of Early Loss of Pregnancy
Allen J. Wilcox, Clarice R. Weinberg, John F. O’Connor et al. · New England Journal of Medicine · 1988 · 2.3K citations
Global Action Plan on Antimicrobial Resistance
Microbe Magazine · 2015 · 2.3K citations
WORLDWIDE PATTERNS OF INFERTILITY: IS AFRICA DIFFERENT?
Willard Cates, Timothy M.M. Farley, Philip Rowe · The Lancet · 1985 · 397 citations
Medicine, Gynecology, Obstetrics +13